Literature DB >> 6824314

Cooperative formation of omega-muricholic acid by intestinal microorganisms.

H Eyssen, G De Pauw, J Stragier, A Verhulst.   

Abstract

Three anaerobic bacteria, isolated from the ceca of rats and mice, converted, through a concerted mechanism, beta-muricholic acid, the predominant bile acid in germfree rats, into omega-muricholic acid. One isolate was a Eubacterium lentum strain; the second and third isolates were tentatively identified as atypical Fusobacterium sp. strains. The conversion of beta-muricholic acid into omega-muricholic acid proceeded in two steps: E. lentum oxidized the 6 beta-hydroxyl group of beta-muricholic acid to a 6-oxo group, which was reduced by either of the two other species to a 6 alpha-hydroxyl group, yielding omega-muricholic acid. This transformation occurred both in vitro and in gnotobiotic rats. Monoassociation of germfree rats with the E. lentum strain gave rise to an unidentified fecal bile acid, probably a derivative of beta-muricholic acid having a double bond in the side chain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824314      PMCID: PMC242244          DOI: 10.1128/aem.45.1.141-147.1983

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  30 in total

1.  Role of the cecum in maintaing 5 -steroid- and fatty acid-reducing activity of the rat intestinal microflora.

Authors:  H Eyssen; M Piessens-Denef; G Parmentier
Journal:  J Nutr       Date:  1972-11       Impact factor: 4.798

2.  Biohydrogenation of sterols by Eubacterium ATCC 21,408--Nova species.

Authors:  H J Eyssen; G G Parmentier; F C Compernolle; G De Pauw; M Piessens-Denef
Journal:  Eur J Biochem       Date:  1973-07-16

3.  Determination of bile acid conversion potencies of intestinal bacteria by screening in vitro and subsequent establishment in germfree rats.

Authors:  A B Dickinson; B E Gustafsson; A Norman
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  The intestinal flora of colonization-resistant mice.

Authors:  F Wensinck; J G Ruseler-van Embden
Journal:  J Hyg (Lond)       Date:  1971-09

5.  Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure.

Authors:  A Arank; S A Syed; E B Kenney; R Freter
Journal:  Appl Microbiol       Date:  1969-04

6.  The persistent absence of Enterobacteriaceae from the intestinal flora of mice following antibiotic treatment.

Authors:  D van der Waaij
Journal:  J Infect Dis       Date:  1968-02       Impact factor: 5.226

7.  A modified gas-liquid chromatographic procedure for the rapid determination of bile acids in biological fluids.

Authors:  P P Nair; C Garcia
Journal:  Anal Biochem       Date:  1969-04-11       Impact factor: 3.365

8.  Bile acid transformations by microbial strains belonging to genera found in intestinal contents.

Authors:  T Midtvedt; A Norman
Journal:  Acta Pathol Microbiol Scand       Date:  1967

9.  Fecal neutral steroids and bile acids from germfree rats.

Authors:  T F Kellogg; B S Wostmann
Journal:  J Lipid Res       Date:  1969-09       Impact factor: 5.922

10.  Isolated fecal microorganisms capable of 7-alpha-dehydroxylating bile acids.

Authors:  B E Gustafsson; T Midtvedt; A Norman
Journal:  J Exp Med       Date:  1966-02-01       Impact factor: 14.307

View more
  15 in total

1.  Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method.

Authors:  Juan C García-Cañaveras; M Teresa Donato; José V Castell; Agustín Lahoz
Journal:  J Lipid Res       Date:  2012-07-19       Impact factor: 5.922

2.  Formation of hyodeoxycholic acid from muricholic acid and hyocholic acid by an unidentified gram-positive rod termed HDCA-1 isolated from rat intestinal microflora.

Authors:  H J Eyssen; G De Pauw; J Van Eldere
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

3.  Delta 22-beta-muricholic acid in monoassociated rats and conventional rats.

Authors:  T Kayahara; T Tamura; Y Amuro; K Higashino; H Igimi; K Uchida
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

4.  Biotransformation of linoleic acid and bile acids by Eubacterium lentum.

Authors:  H Eyssen; A Verhulst
Journal:  Appl Environ Microbiol       Date:  1984-01       Impact factor: 4.792

5.  12 beta-dehydrogenation of bile acids by Clostridium paraputrificum, C. tertium, and C. difficile and epimerization at carbon-12 of deoxycholic acid by cocultivation with 12 alpha-dehydrogenating Eubacterium lentum.

Authors:  R Edenharder; J Schneider
Journal:  Appl Environ Microbiol       Date:  1985-04       Impact factor: 4.792

6.  Effect of chitosan feeding on intestinal bile acid metabolism in rats.

Authors:  Y Fukada; K Kimura; Y Ayaki
Journal:  Lipids       Date:  1991-05       Impact factor: 1.880

7.  Isolation of a rat intestinal Clostridium strain producing 5 alpha- and 5 beta-bile salt 3 alpha-sulfatase activity.

Authors:  J Robben; G Parmentier; H Eyssen
Journal:  Appl Environ Microbiol       Date:  1986-01       Impact factor: 4.792

8.  Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota.

Authors:  Annika Wahlström; Petia Kovatcheva-Datchary; Marcus Ståhlman; Muhammad-Tanweer Khan; Fredrik Bäckhed; Hanns-Ulrich Marschall
Journal:  J Lipid Res       Date:  2016-12-12       Impact factor: 5.922

9.  A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model.

Authors:  François-Pierre J Martin; Marc-Emmanuel Dumas; Yulan Wang; Cristina Legido-Quigley; Ivan K S Yap; Huiru Tang; Séverine Zirah; Gerard M Murphy; Olivier Cloarec; John C Lindon; Norbert Sprenger; Laurent B Fay; Sunil Kochhar; Peter van Bladeren; Elaine Holmes; Jeremy K Nicholson
Journal:  Mol Syst Biol       Date:  2007-05-22       Impact factor: 11.429

10.  Muricholic acids inhibit Clostridium difficile spore germination and growth.

Authors:  Michael B Francis; Charlotte A Allen; Joseph A Sorg
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.